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ABSTRACT. 
Introduction: Sub Saharan Africa is home to approximately two thirds of the world’s 
population of HIV positive individuals. In view of the socioeconomic challenges of the 
region governments have provided antiretroviral therapy free to improve chances of 
survival among patients. However, adherence to antiretroviral therapy is recognised as 
more important in predicting patient survival. 
Setting: This study has been conducted among adult patients attending the Dora Nginza 
Hospital Adult wellness clinic. 
Aim: The study aimed to describe the prevailing factors that influence adherence to 
antiretroviral therapy. 
Methods: The study design was carried out using three methods of data collection. Focus 
group discussions, semi structured interviews and a questionnaire format. 
Results: The methods highlighted factors that influence antiretroviral therapy revealing 
psychosocial factors – lack of family support, not wanting to take medicines in front of 
people outside the home; patient factors – co morbidities that disturb patient adherence to 
therapy, a lack of trust in the patient-care giver relationship, fear of the drug side effects; 
socioeconomic factors – patients’ inability to afford food or transport costs to clinic 
appointments. In the semi structured interviews, 25% of patients self reported on poor 
adherence while in the questionnaire 5% of patients reported poor adherence. In assessing 
the effect of adherence to therapy on CD4 count and viral load there was a general 
increase in CD 4 count and a drop in viral load indicating clinical improvement in 
patients on therapy. 
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Recommendation: There is a need for clinicians developing a health relationship with 
patients to facilitate adherence. The interventions designed to help patients in adherence 
to therapy should involve the patients in question in the designing of these interventions.  
Conclusion: Adherence monitoring is an important aspect of managing patients on 
antiretroviral therapy. The factors highlighted are similar to findings of other studies in 
similar contexts i.e. resource poor settings. 
 
 
INTRODUCTION 
 
The United Nations Program on AIDS and the World Health Organisation estimated that 
at the end of 2005, about 40 million people around the world were living with HIV. The 
majority of these people are believed to live in Sub Saharan Africa, and in this region the 
Southern African countries are believed to have the highest rates of infection. 
Unfortunately, Sub Saharan Africa is the poorest region in the world rendering the 
devastating effects of the pandemic far reaching for the families of affected patients and 
the economy of the region. These effects influenced the choice of governments in the 
region to provide free antiretroviral therapy for indigent citizens of their countries. 
However, making the drugs available is only one aspect of a multifaceted problem 
requiring interventions at many levels to have a positive effect and reverse the trend of 
increasing numbers of people with HIV infection. It has since been discovered that 
providing drugs is only solving part of the problem which without adequate supervision 
creates an even bigger problem, if patients are poorly adherent to therapy. It has been 
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noted that poor adherence to antiretroviral therapy is associated with  a failure of viral 
suppression and a development of resistant strains which when spread cause increasing 
difficulty in achieving virologic suppression and improved immunologic status of the 
patients. 
 
This study was set in the Wellness clinic of the Dora Nginza Hospital where the majority 
of patients are referred from the clinics or the hospital inpatient wards for management of 
their HIV status. A large number of these patients were referred from the local clinics for 
failure of virologic suppression on Regimen 1A or 1B of the Department of Health’s 
protocol for Highly Active Antiretroviral Therapy (HAART). In a number of instances 
the patients reported poor adherence as the cause of the reason for failure in achieving 
virologic suppression and persistently low CD4 cell counts. In the experience of the 
researcher  with the patients, non adherence is a common trend and this often results in 
poor outcome. The effect of poor adherence to antiretroviral therapy has far reaching 
implications. When the patients deteriorate, it becomes even more difficult for a lot of 
them who are breadwinners in their families to source basic necessities for their families. 
The result is that more than one person suffers from the patient’s non adherence. Many 
studies have been carried out in various other centres but no study has been carried out 
locally. The common factors for non adherence have been described as ranging from 
poverty, hunger, lack of family support, drug and alcohol abuse to name a few. The 
extent to which these factors affect the patients at this clinic is not well described in any 
study. It is essential to have the extent of these factors documented in order to implement 
proper interventions designed to the specific needs of the patients at this clinic. 
 10 
LITERATURE REVIEW. 
 
The human immunodeficiency virus (HIV) has come a long way since it was first 
described in the 1980s and then associated with AIDS and its high mortality. Since the 
advent of antiretroviral therapy, it is understood that patients can be managed over long 
periods with antiretroviral therapy once virologic suppression and the improvement of 
CD4 count are achieved. However, in the light of this development, a new challenge is 
being faced.  It has become increasingly difficult to maintain virologic suppression and 
immunologic improvement if patients are poorly adherent to therapy. In questioning the 
amount of adherence to HAART considered optimal, review of the literature
1
 reveals  it 
is uncommon to find patients with clinical failure. Bangsberg et al suggest that even with 
development of resistant strains of HIV there is always residual anti HIV activity in the 
ARV medication that helps patients stay clinically well in most instances of poor 
adherence
1
. It however concurred with other studies that the need for strict adherence can 
not be overestimated as the goal of therapy must remain complete virologic suppression 
and good immunologic response. Studies have reported that >95% adherence is required 
to achieve optimal suppression as lesser levels of adherence are associated with treatment 
failure and poor outcome in the long term
2
.  
Poor adherence is common and in a lot of instances reasons for this is related to 
forgetting to take the doses as required. A study carried out at a private sector disease 
management program for beneficiaries of contracted medical insurance funds in South 
Africa set out to confirm that adherence to highly active antiretroviral therapy does in fact 
influence survival as it is associated with “a three fold decrease in mortality hazard 
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among HIV 1 infected South African adults”3. There is a paucity of studies from Sub 
Saharan Africa but a systematic review
1
 done in 2005 into factors affecting adherence to 
highly active antiretroviral therapy (HAART) gathered a total of 84 studies, 37 
qualitative studies and 47 quantitative studies from developed and developing nations. It 
revealed that a lot of studies carried out in developed and developing nations had similar 
factors affecting adherence. Described as barriers to adherence, these factors were 
grouped into 3 major groups namely: patient related factors; beliefs and daily schedules
3
.  
The patient related factors included factors such as fear of disclosure, avoiding taking 
medication in public, depression, drug and alcohol addiction, suspicions of treatment, 
preferring a natural approach, denial of HIV status, lack of self worth, financial 
constraints and concurrent illnesses affecting adherence. Factors influenced by beliefs 
included; adverse effects of medication, complicated regimens, feeling better affected 
adherence and decreased quality of life. Patients also reported busy schedules preventing 
them from refilling their prescriptions
4
.  
Patient reported facilitators of adherence included, acceptance of status, improved health 
status in response to HAART, simple regimens, the use of reminder tools and successful 
positive interpersonal relationships
4
. Another review of the literature which examined 
adherence to antiretroviral therapy
5
 mentioned the predictors of adherence, having 
grouped them into factors associated with patient variables, factors associated with 
treatment regimen, factors associated with disease characteristics, factors associated with 
patient provider relationships and factors associated with the clinical setting. The factors 
associated with patient variables include socio-demographic factors and psychosocial 
factors. The psychosocial factors are commonly associated with being good predictors of 
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adherence e.g. depression, substance abuse, stressful life events,  lack of social support, 
poor knowledge of drug regimens and the relationship between adherence and 
development of resistance. Factors associated with treatment regimen are associated with 
how complicated the regimen is and the adverse effect of the antiretroviral therapy. 
Factors associated with the disease include stage and duration of disease especially 
number of opportunistic infections; it described how some studies have shown that ill 
health stokes the desire for good health hence driving the motivation for adherence to 
therapy. Factors associated with patient provider relationships describe the fact that 
patients tend to be better adherent when they have a good relationship with the care 
provider, i.e. physician and other health workers at the health facility. Factors associated 
with clinical setting include the access to a primary care centre, involvement in an 
adherence program, convenience of appointments and pleasantness of clinical staff.
5
 
 
An attempt to compare adherence among patients in Sub Saharan Africa a third world 
setting and North America a first world setting revealed that the problems encountered in 
Sub Saharan Africa are still not on the scale of poor adherence encountered in North 
America. In other words, there are still too few cases to make a comparison between both 
regions but it is well described that in North America adherence to HAART is a big 
problem
6
. The paper stated that adherence though a big problem in both regions, the 
differences in living standards of patients does not allow for a justifiable comparison. The 
paper does agree that adherence is the “single most accurate predictor of good patient 
outcome in the fight against HIV/ AIDS.”6 The paper assessed studies with patients who 
completed the studies and adherence measures were assessed as primary adherence 
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thresholds. In studies where more than one method was used to assess adherence it chose 
the most objective in reporting the findings.  Again it is important to mention that there is 
no gold standard for measuring adherence to HAART. This is part of the dilemma 
investigators face in trying to measure the problem. 
Pence BW et al
7
 conducted a study to assess the influence of psychosocial characteristics 
duration of use and the success of HAART, assessed the rate of commencing and 
discontinuing ART among patients based on psychosocial factors and found that patients 
with unfavourable psychosocial factors were less likely to be commenced on ART, were 
more likely to stop ART and have failure of virologic suppression.  
In a similar study conducted to assess the effect of adverse life events
8
 , Mugavero et al 
identified factors like depression, drug and alcohol abuse, stress, lower levels of 
education, physical and / or sexual abuse are associated with higher levels of non 
adherence among patients. The authors suggested assessing the risks for non adherence 
prior to commencing HAART and designing interventions to help patients with these 
factors.  The aim will be to aid them in dealing with these issues prior to starting 
HAART. The expected result is increased adherence to HAART.  
Murri et al
9
 stated that physicians had poor estimations of adherence in patients with 
lower levels of education, unemployment and where there were no social workers 
available at the clinic. Their study suggested that poor concordance in the estimation of 
adherence between patients and their physicians were likely to be associated to poor 
clinical decisions by physicians in the management of HAART. It states that to achieve 
better levels of adherence in these clinics, interventions be designed to improve the 
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relationship between physicians and patients. Physicians will need to acquire a better 
understanding of their patients’ context. 
 
In the study by Ammassari et al
10
 on depressive symptoms and neurocognitive 
impairment and adherence to HAART, they described how 28 to 100% of patients fall 
below the required levels of adherence. Their study showed that 50% of patients 
diagnosed with HIV have depressive symptoms or symptoms of neurocognitive 
impairment, these individuals are said to develop the accelerated form of HIV 
independent of virologic suppression or improved CD4 count. It suggested the need to 
actively manage these patients in order to improve their outcome as depression and 
neurocognitive impairment also negatively impact on adherence to HAART. 
There is a need to assess patients starting HAART for predictors of adequate/inadequate 
adherence. The guideline
11 
lists predictors of inadequate adherence and adequate 
adherence. The predictors of inadequate adherence include a lack of trust in the patient 
physician relationship, active drug and alcohol abuse, active mental illness, lack of 
patient education, inability of patients to recognize their medication and lack of access to 
primary health care or medication. The predictors of adequate adherence on the other 
hand include availability of adequate emotional and practical life supports; ability of 
patient to use medication in their daily routine; understanding the importance of strict 
adherence; feeling comfortable with taking medication with others present; keeping clinic 
appointments. The guideline identifies that though there is no gold standard of assessing 
adherence, a patient’s admission of suboptimal adherence is a reliable method of 
assessing adherence. The clinician’s estimation of adherence is considered to be 
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unreliable. It suggests that having patients bring their diaries of drug ingestion and their 
left over pills and paying attention to situations where doses were missed with the intent 
to preventing future occurrences is important. The guideline suggests multi focused 
strategies of intervention involving the clinician, the patient, the regimen/ doses and 
directly observed therapy. Suggestions for patient directed strategies include the 
education of patients. Especially, according to their literacy level and address issues like 
the goal of therapy, side effects of therapy, education of family and friends. Clinician 
directed strategies are to include adequate communication with patients in between visits, 
having a non judgmental attitude, looking out for problems like pill fatigue (a recognized 
phenomenon in suboptimal adherence especially after taking medication for a prolonged 
period), shortening follow up intervals, involving the help of social workers and 
counsellors in patients assessment. Regimens should be simplified and patients be 
educated to recognize the medication, DOT has not been proven to be of effect in 
prolonged therapy like HAART
11
.
 
Hardon et al set out to outline the socio-demographic factors encountered in Africa which 
influence adherence to antiretroviral therapy
12
 it used qualitative methods of assessment 
(semi structured interviews, focus group discussions and exit interviews) to gather 
information from ART users and people working with these patients. The factors outlined 
in the results of the study include poverty as a lot of the patients could not afford food 
(which was required to regain adequate health after starting HAART) or the cost of 
transport to the health facility, other factors outlined include stigma as a number reported 
loosing their jobs after disclosure of their status, a number of these patients reported non 
disclosure so they had no social or emotional support, a lot of patients skipped doses due 
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to side effects of the medication. A qualitative study
12
 not dissimilar from the one the 
researcher intends to conduct, was carried out in resource poor settings across three 
countries of Tanzania, Uganda and Botswana, the findings suggested that patients started 
on ARVs end up with suboptimal or non adherence often due to patient related or drug 
related factors, it listed factors like transport costs, inability to get food, non disclosure 
causing poor social support as those who disclose their status are abandoned by family 
and friends or lose their jobs as a result of stigma associated with HIV, substance and 
alcohol abuse are said to also play a role in poor adherence among these patients. The 
findings revealed that often patients are not adequately counselled about the side effects 
of medication causing them to become non adherent when they start having the adverse 
effects of medication also a number found the regimens too complicated with a huge pill 
burden, the exit interviews conducted during the study revealed that only 21% of patients 
coming to clinic had counselling. The factors in the resource poor settings have been 
described as being largely economic related factors among the indigent patients. The 
study went on to state that  the increasing numbers of patients being put on ARV therapy 
with no increase in the number of health workers is causing a huge burden on the system 
and may be indirectly associated with poor adherence in these settings. 
Recommendations by the study include the provision of transport and food for the very 
needy, the provision of three monthly medications for the patients who are known to have 
optimal adherence to avoid recurrent transport costs, provision of good counselling to all 
patients being commenced on ARV about side effects of medications
13
.      
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In rural Haiti,
12
 a study was based on reviewing how strategies designed to address 
barriers to adherence to ARVs improved adherence among patients in the community. 
These strategies were designed against poverty associated barriers and included free 
health care and medication services including the provision of integrated services for the 
treatment of tuberculosis, sexually transmitted infections and an ‘opt out’ testing program 
for all patients with possible HIV related disease. For patients who were largely from the 
indigent community, provision of small funds for transport to the clinics and food parcels 
and the use of community health workers in active case finding and psychosocial support 
among the community, the results reported markedly improved rates of adherence among 
these patients. The recommendations from this study go on to suggest that all ARV roll 
out programs must assess the barriers to adherence which may prevent the success of 
these programs in the long term and should set out to forestall these by having programs 
that will address these barriers especially the poverty related barriers such as were carried 
out in rural Haiti. A similar study carried out in Khayelitsha
13, South Africa’s first 
Primary care ARV roll out program using triple therapy, revealed that having strategies 
that address possible barriers to adherence improve the outcome of patients allowing for 
successful virologic suppression without a subsequent rebound leading to treatment 
failure due to poor adherence. A study in rural eastern Uganda
15
 revealed that home 
based care and monitoring of patients on ARVs in the rural setting can achieve higher 
levels of adherence in the short term especially among patients having difficulty with 
transport costs and food. This study was a longitudinal follow up study that formed part 
of a bigger study on the effect of ARVs in improving outcome
14
. Another study, suggests 
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that the problem of missing doses is not the only one to be associated with suboptimal 
disease control. It stressed the importance of having optimal intervals between doses
16
.           
 
The studies included in this review all confirm that various factors influence adherence 
and these factors are often patient related, to do with the patient context and other 
pressing medical problems, which are common among these patients.  
 
AIM. 
 
The aim of this study is to obtain a deeper understanding and describe the prevailing 
factors that influence adherence to antiretroviral therapy in adult patients attending the 
Dora Nginza Hospital Wellness clinic. 
 
OBJECTIVES. 
 
 To assess the prevailing factors associated with poor adherence or non adherence 
among patients at the clinic. 
 To obtain a deeper understanding of the factors associated with non adherence in 
patients at the clinic 
 To describe the relationship of poor or non adherence to virologic suppression and 
clinical status of the patient. 
 To describe the prevalence of poor adherence among patients on antiretroviral 
therapy at the Dora Nginza hospital wellness clinic. 
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METHODS 
Study design 
This is a study that involved obtaining a deeper understanding of the factors that 
influence adherence among the patients at this clinic and therefore the most suitable 
methodology is interpretive with a qualitative study design. 
Context 
The wellness clinic at Dora Nginza Hospital has about 1200 patients currently on 
antiretroviral therapy (ART). This study involved the use of focus group discussions and 
in-depth interviews with both patients and health workers at the clinic in order to assess 
the prevailing factors that influence adherence to therapy among the antiretroviral users. 
This clinic serves as a referral clinic to the outlying clinics for patients who have had 
treatment failure due commonly to poor adherence; it also manages in-patients with HIV 
related complications requiring a fast paced adherence program but in a number of 
instances it is a wellness clinic for ART naïve patients just starting therapy.  The focus 
group discussions was set up with the help of health workers at the clinic and aimed to 
have patients air their views about the problems they faced as they committed themselves 
to the use of ARV therapy for life.  The in-depth interviews were aimed at a sample size 
of 20 patients who are on the ARV program. These patients were chosen randomly from 
the population of patients attending the clinic while waiting for their appointment with 
the health workers. A list of patients in attendance at the clinic were drawn up each day 
during a two week duration. 2 patients were randomly selected from the patient line up 
for interview on each of the days from Monday to Friday. A number of questions were 
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drawn up to help the researcher while conducting the in-depth interviews with directing 
the interviews so the patients gave the required information in their own language as 
much as possible but without missing out information relevant to the study. In an attempt 
to confirm the credibility of the results, the researcher conducted a small quantitative 
study by handing out questionnaires to a sample of about 200 patients to collect 
information in this regard. In other words, the researcher used different methods of data 
collection in an attempt to enhance the credibility of the results.  
 
The strengths of the qualitative study include 
 it focuses on the patient as a social being and not as a physiologic system, while 
giving an accurate reflection of the factors; 
 it describes the factors influencing adherence among these patients as they are;  
 small numbers are acceptable and the data collected was easier to analyse; 
Possible limitations of the interpretive method include the fact that:   
 The findings are context specific and transferability to all wellness clinics but this 
one is restricted. 
 The focus group discussion method did not allow for keeping patient 
confidentiality and this is where it was important that the researcher ensured that 
all patients being enrolled for the focus group discussions were fully aware of the 
fact that proceedings were being recorded and were comfortable talking about 
their HIV status in the presence of other similarly infected patients. 
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This study made use of method triangulation where different methods of data collection 
from different paradigms are combined, in an attempt to enhance the credibility of the 
results and obtain convergent validity. 
 
Reflexivity 
In conducting this qualitative research I have had to look inwards to understand what 
mindsets and biases I bring to the study.  
I am a medical professional in my mid thirties, practising now in South Africa for six 
years and happily married for 7 years. In taking a deeper look I go back further. I am a 
Nigerian woman born to parents who are themselves medical professionals, my father a 
medical doctor and my mother a Nurse midwife. I am the first of 5 siblings. I was born to 
a Christian family and brought up with Christian values and a strong sense of family. 
Children outside wedlock is unheard off in my home, fidelity is absolutely not negotiable 
and everyone is expected to surpass the dreams of our parents. I now work in this 
community where the family is largely fragmented as a lot of my patients are born to 
single parents and women do not want marriage. I see young girls opting to have teenage 
pregnancies not because they can’t avoid this but because it is the trend among their 
peers. 
I believe the HIV pandemic could have been avoided, if moral values of fidelity and care 
for the other person were held higher in the society. Now we have this pandemic and the 
governments of the Region have helped with the free ARV roll out campaigns, it is time 
to make the best of the programs and use the opportunities. 
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I have tried to understand the thinking of the HIV positive individual in the community 
where I work. When they are started on antiretroviral therapy, they have such zeal and 
commitment to the use of their medication. They understand the importance of strict 
adherence to therapy. What happens in between the time they start therapy and when they 
start defaulting? Why would they risk falling ill with increased chances of mortality? 
Can’t they understand that to miss doses is risking treatment failure? I set out to 
understand the factors influencing adherence among the population of my patients. In my 
interactions, I have seen people who have the same dreams of wanting to live, love and 
be happy. They know the implications of non adherence and tell of their wanting to 
improve adherence but some describe frustratingly difficult social circumstances. I begin 
to see that may be the choices they make are largely due to giving up on wanting to 
achieve their dreams. They just want to get by from one day to the next and may be at 
some time life will not be so difficult. I have never known poverty and so I can’t tell how 
desperate people can be when faced with the challenges of finding the next meal to 
survive. Is this why adherence is a problem? The challenge of facing death from hunger, 
giving up on the choice to take medication as adherence is pointless in the face of not 
being able to feed. What about the stigma described by these patients? They are rejected 
by family, ostracized by friends, alienated by community. The quiet whispers of ‘she is 
promiscuous that is why she got HIV’ that are spoken when a very pretty young girl 
walks past on the street are these enough reason to stop taking therapy? Are they enough 
reasons to give up on the will to live, love and be happy? They default therapy for fear of 
the new boyfriend finding out about their HIV positive status. She risks his life and 
engages in unsafe sex with him to be happy, if only for a short while. I have heard the 
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various reasons given by patients in this study, they seem enough reasons for these 
patients to give up on love but surely not living. I am challenged however, in the face of 
all the social problems described by these patients, what can be done to turn the trend? Is 
there any thing to be done to stop the problem of poverty or non adherence?  
 
Piloting the study. 
The initial pilot study involved the use of a short questionnaire highlighting demographic 
data without the patients’ names in an attempt to maintain patient confidentiality. The 
other facts included questions about the number of doses missed in the preceding week to 
answering the questionnaire and the reason/reasons for missing the doses. The in-depth 
interviews were conducted by the researcher and were aimed at asking questions to 
obtain a deeper understanding and meaning of the factors associated with adherence to 
antiretroviral therapy. The aim of the pilots was to assess the feasibility of the study 
design and to introduce any changes required to improve and to make the designs more 
feasible. The pilot was conducted among 3 patients for the in-depth interviews and 10 
patients for the questionnaires. The focus group discussions were not piloted but the 
questions required for guiding the discussion groups were tested with the questionnaire 
and the in-depth interviews. 
Data collection procedure. 
The researcher aimed to collect data over a 4 month period and sampling of the patients 
was random. Patients were seen at the clinics and had numbers allocated to them in order 
of arrival. Patients were chosen by randomly selecting the numbers manually on the 
different clinic dates. The patients were selected for the questionnaire study and the in-
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depth interviews on separate days and data collection was done at different times. Staff at 
the wellness clinic were aware of and fully supported the program. Before each 
questionnaire was completed, focus groups compiled or in-depth interview conducted, the 
selected patients signed informed consent forms and there was no coercion of patients to 
join the study.  
 
Data analysis. 
Qualitative and quantitative data analysis was conducted. It is important to state that the 
objective of the qualitative data analysis is not to interpret data in numerical language but 
rather to explore ‘conceptual definitions’, group data based on the similarity of responses 
and meanings, associations and explanations. The method used in analysis was 
systematic, keeping a focus on the data collected as it is and developed through reflection 
on the meanings of each statement.  
The steps were as described below: 
1. Familiarization : This step required that I got to know the data well and this is why it 
was essential that I collate the information which was verbal on tapes for the focus group 
discussions, and written in long hand in the in depth interviews. I reflected on the 
meaning of each statement before putting the findings down. 
2. Indexing: This involved identifying the various parts of the data and marking them in 
some way making them accessible as they held information pertinent to the findings of 
the study. 
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3. Grouping data: This involved sorting the data into segments based on the similarity of 
information they held as to the patients’ views. The data when grouped in this way 
allowed for easier reflection on the various parts of the study. 
4. Development of themes: following the last stage, reflection on the data allowed for me 
to create themes based on the data in the various groups. The data reporting was greatly 
dependent on the researcher being able to define the theme of each group and reporting 
reflections and perceived meanings. 
 
The above steps highlight how the researcher analyzed the qualitative data from the focus 
group discussions and the in-depth interviews.  
 
A Biostatistician was consulted early to assist with sample size, and the analysis of the 
quantitative data and the excel software package was used. The recommendations made 
were noted and implemented with the data analysis. The findings of the quantitative study 
were compared with the findings of the other two methods used. The researcher then 
discussed the findings, reporting in the context of the study.    
 
Ethical Considerations 
 
This study sought to describe the factors associated with poor adherence among HIV 
positive individuals to antiretroviral therapy. HIV poses a challenge when it comes to 
ethics as there is the continuing problem of stigmatization and the fact that a number of 
patients still have difficulty with disclosure of their status. The study sought to consider 
 26 
the participants as the primary concern, the culture, language, customs and beliefs of each 
participant were considered as the researcher tried to gain insight into the issues of 
adherence that presented during the study. This study is of great relevance to this 
community as it faces huge challenges regarding patient adherence to antiretroviral 
therapy and the findings so far will go a long way in helping to design interventions to 
help the attendants at the wellness clinic with improving adherence. The study was 
conducted keeping in mind the importance of good methods designed to give answers to 
the research question. The researcher conducted a review of the literature which is 
continuing to help with gaining an adequate knowledge of the problem.  
The responsibility of the principal investigator in this study was to be compassionate and 
empathic, ensuring that the study was done abiding by all ethical standards and good 
clinical practice prescribed for this type of a study. Permission to conduct this study was 
obtained from the superintendent of the Dora Nginza Hospital, see addendum 6. 
Informed consent. 
The study used 3 methods to gather the information required and all the patients involved  
gave informed consent having been fully briefed of what their participation required, 
what the study is about and what the results will be used for. They were made aware of 
the fact that their confidentiality and anonymity is protected at all times. A right thumb 
print was used in patients who could not write to show their approval and consent for 
their involvement in the study. See addendum 2. 
Confidentiality. 
This was a rather difficult challenge to overcome given that there were focus group 
discussions aiming to gather data for the study. The facilitator for the group discussions 
 27 
was the researcher, and all the facts of the study are strictly confidential, no names were 
used in the course of interactions during the discussions as patients needed to remain 
anonymous. 
Protecting the interests of the research participants 
As is protocol for all ethically sound studies the patients were fully aware of their rights 
to withdraw from the study at any point in time. More so, this study is based on HIV, an 
area of medicine that is still associated with unfair stigmatization of patients affected by 
the disease. In the spirit of patient advocacy the participants had all their personal data 
kept confidential at all times. Anyone involved with the study was directly involved with 
patients at the clinic and to ensure this, the researcher validated the identities of all staff 
prior to any data collection exercise started and when looking in patients folders for 
information to supplement the questionnaires the folders were not removed from the 
clinic records office. 
Freedom to draw unbiased conclusions from the results 
The study has been carried out with the aim of helping to design adequate intervention 
for the management of patients with difficulties associated with adherence. The findings 
of the study will be reported as they are with no attempts to give an altered picture. There 
will be no undue external influence to make untrue representation of the results and all 
findings of the study are subject to peer review.   
 
 
 
 
 28 
 
Results 
Focus Group Discussion 
Two focus group discussions were held, each one consisted of 20 people including lay 
counsellors, peer educators and patients. Both discussions were coordinated by the 
researcher and participants signed informed consent before each session. The sessions 
were recorded and the focus was to describe the factors that were said to influence 
adherence to antiretroviral therapy among participants. In analysing the results, the 
researcher developed themes as they arose from the transcribed script of the discussions 
proceedings. The themes were then grouped and this formed the basis of the results 
presented here. The researcher has also attempted to give quotations from the discussions 
under each factor identified in the course of the discussions. 
The instances described include the following: 
- The health workers impression of poor or non adherence are sometimes based on 
inaccurate reports of the number of pills dispensed to patients. As reported by one 
of the participants, ‘how do the nurses know that I am defaulting my therapy if 
they do not count my pills at the pharmacy, when they are dispensed because 
when I receive the bottle it is sealed?’ 
- Patients often missed doses because they were out of their home environment, 
some were at work and would often forget to take their medication because they 
were distracted by their work schedule, and other patients would not take pills 
outside their home for fear of someone seeing that they were on antiretroviral 
medication. A participant reported working with sick patients at a hospital in the 
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metropole, she would dispense the patients’ medication when she was due to take 
her medication and often took her medication late. Some reported being away 
from their station at work at the time when they were to take medication. This 
often resulted in taking medication late and on occasion if more than two hours 
had elapsed they would default that dose and wait for the next dose. A participant 
who works as a domestic worker, described a very busy schedule at work. She 
also expressed fear of her boss seeing her taking her antiretroviral therapy so she 
would often not take her medication to work, she believed she would lose her job 
if her boss found out about her HIV positive status. A participant said ‘I went to 
visit a friend over the weekend and missed a dose because I did not take enough 
pills.’  
- The use and abuse of alcohol was often a reason to miss doses for some patients 
because they could not take their medication with alcohol and after binging on 
alcohol would have the hangover effects so they slept through the time they were 
to take their medication. One participant reported, ‘I went out with friends over 
the weekend and got very drunk, I missed my dose for that night, the next day I 
woke up at half past one (past noon the next day), I had missed my dose for the 
morning by 4 hours so I decided not to take it’.  
- Some patients lacked family support and found it very difficult to keep up with 
therapy without the support of family members. In some instances there was 
family violence resulting from the disclosure of status which resulted in 
depression, alcohol abuse and defaulting antiretroviral therapy. A participant 
reported how he turned to alcohol following rejection by his father on account of 
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his HIV status. He was ostracised by his father on account of his HIV positive 
status which he disclosed to the community. 
- Some patients described the challenges of caring for sick children without family 
support and how this made it difficult to keep up with their personal health. A 
participant recounted how she had been rejected by the boyfriend on account of 
not wanting to be associated to her for being HIV positive and rejecting her child 
who was ill following vertical transmission in pregnancy. 
- Some patients defaulted treatment due to not having support from their partners, 
this resulted in depression, with suicidal thoughts in more than one participants’ 
report. A patient reported having defaulted her therapy because her partner was 
not in support of her taking antiretroviral therapy. A peer educator spoke of how 
she hid her pills from her new boyfriend so he would not know she was HIV 
positive. 
- Some patients defaulted treatment because of severe financial constraints, they 
could not afford to buy food to eat so they defaulted treatment if they did not eat. 
Numerous participants in the group discussions reported not taking pills if they 
did not have food to eat. The peer educators admitted that this was a common 
finding among patients they counselled in the wellness clinic. They expressed 
worries that the government sometimes withdrew social grants from patients who 
were very dependent on the social grants for sustenance. 
- Some revealed instances of defaulting therapy to drop their CD4 count so they 
could remain on government social grants. A participant said in reporting a third 
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party, ‘people are making themselves sick by not taking medication, so they can 
get the social grant’.  
-  Some patients defaulted treatment because they dropped their medication on the 
floor and considered it not safe for consumption after this and would run short of 
pills before their next appointment because of discarding ‘dirty’ medication. A 
patient said he was afraid to tell the nurses that did the pill counting that even 
though he had the right number of pills left over at his pill counting appointment, 
he dropped a few on the floor and never got to take them because the pills were 
too dirty for consumption. The participant admitted that he was afraid because the 
medical personnel would be very displeased. Another said he ‘forgot’ to tell the 
medical personnel that he vomited his pills and so had not been completely 
adherent as they had thought he was.  
- Some patients felt the government was not concerned with their social distresses 
and was only concerned with giving out antiretroviral therapy. They expressed 
discontent that the government stopped some of the social grants after 12 months 
even if they had no other source of income. 
- Some felt the social workers were not concerned about their social problems 
rather they were more interested in getting through their work load. They felt the 
social worker in question expected all HIV positive patients to only want 
registration for social grants. 
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Results of Semi structured Interviews  
The semi structured interviews were conducted by a single interviewer to prevent 
observer bias as patients refused to have recorded sessions of their interviews. 
All patients interviewed were on either Regimen 1A or IB with the exception of one who 
had been started on Regimen 2 at another centre and was being referred to the Wellness 
clinic where this study was conducted. All reported being responsible for taking their 
own medication and had all disclosed their HIV status to family members, and 5 of the 
group had disclosed to people outside of their family which in most instances consisted of 
1
st
 degree relatives. In one case however the patient spoke of how she was ostracized in 
her community and told she was HIV positive because she was promiscuous, another 
patient however spoke of how the community had come to her aid following the death of 
her husband who died of an HIV related disease. Most patients did not disclose their 
status to anyone outside their family. 
When asked to grade their levels of adherence on a scale of 1 to 10, 6 patients admitted to 
less than optimal levels of adherence ranging from 0% to 80%. A 7
th
 patient admitted to 
poor adherence but was unable to comprehend the task of grading himself on a scale even 
though he described poor adherence, an 8
th
 patient described poor adherence but would 
not grade herself on a scale. The patient who graded herself 0% said she had been told to 
discontinue antiretroviral therapy due to severe hyperlactatemia but she had been 100% 
adherent to therapy prior to stopping. Therefore 7 of the 20 patients interviewed were 
poorly adherent to therapy for reasons not due to health intervention. 
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Patients gave various reasons for poor adherence, the most predominant being that 
financial constraints and social problems made it impossible to keep up with adherence as 
required. Patients often described being unemployed, with often no money to buy food 
and being unable, in a lot of instances to afford transport costs to get to the clinic. One 
patient missed 7 days of therapy according to her doctor’s notes in the folder she 
confirmed that she had been due to return for therapy the previous week but could not 
afford transport costs. A lot of the group reported not taking medications if there was no 
food to eat. In 2 instances, the patients were not taking their medication because they had 
poorly controlled co morbidities and without family support were unable to keep up with 
taking their antiretroviral therapy. 2 patients reported adverse effects of the medication 
actually made them default therapy frequently. A patient described feeling angry, 
depressed and helpless about the adverse effects of the medication. Another group missed 
doses because they could not take their medication outside the home as they could not 
take medication with others present or were too busy working and would miss doses 
during work hours. In this group of patients 35% of the total number were poorly 
adherent to their antiretroviral therapy.  
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Results of quantitative study. 
 
 
Figure 1: Histogram of age distribution of participants. 
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A large percentage of participants were in the 25 to 40 years age bracket. 
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Figure 2: Histogram of GENDER 
Histogram of GENDER
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F- Female; M- Male 
Most participants in the study were female(86%) as is the trend at the clinic, more 
females are in attendance than males.  
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Figure 3: Histogram of educational level 
Histogram of 101 EDULEVEL
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83%(4) of respondents were secondary school level education, 10%(3) were primary 
school level, 3%(5) were technical school level education, 1%(6) had diploma level 
education, 1%(1) had never attended formal schooling. 
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Figure 4: Histogram of marital status 
Histogram of 102 MARSTAT
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N – Never married , M- Married, W – widowed, D – divorced, C- Cohabiting,  
S-Separated 
Most respondents(74%) had never been married, 13% were married, 7% were divorced, 
3% were cohabiting and 2% were widowed  
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Figure 5: Histogram of ACCOMODATION 
Histogram of 104 ACCOMODATION
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H-own house, I-Informal housing, R-rented room, O- other accommodation, RH-Rented 
house. 
The majority of participants(77%) lived in RDP housing which is reflected here as own 
independent house (H), 10% of respondents lived in informal housing. 
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Figure 6: Histogram of FACILITIES 
Histogram of 105 FACILITIES
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For feasibility of assessing patients access to basic facilities in housing the access to 
electricity was noted, some participants who lived in informal housing had a radio. 96% 
of respondents had access to electricity. 
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Figure 7: Histogram of WATERSOURCE 
Histogram of 106 WATERSOURCE
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89% of respondents had access to piped borne water in their homes while 11% had to 
fetch from the community tap. 
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Figure 8: Histogram of toilet facilities 
Histogram of 107 TOILET
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A total of 92% of participants had access to flush toilets, 4% had no toilet facilities and a 
further 4% had access to traditional pit latrines. 
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Figure 9: Histogram EMPLOYED 
Histogram of 108 EMPLOYED
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The majority of respondents were unemployed, 81%, only 19% were either full time or 
part time employed. 
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Figure 10: Histogram of type of occupation 
Histogram of 110 OCCUP
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Only 14% of the employed participants were skilled, majority were involved in one form 
or the other of community work e.g. lay counsellors. 
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Figure 11: Histogram of patients disclosure to family 
Histogram of 201 HIV DISCLOSE
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Only 1% of participants had not disclosed to members of their family. 
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Figure 12: Histogram of support received from family. 
Histogram of 204 SUPPORT
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N- No support, E- Encouragement and psychological support, F- financial support, 
PC- physical care, ALL- All forms of support. 
The majority of patients received some form of support from family members.  
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Figure 13: Histogram reflecting patient satisfaction with support received 
 
Histogram of 205 SATISFIED
Sheet1 in DATA 20090806.stw 78v*240c
3% 1%
5%
91%
1 2 3 4
205 SATISFIED
0
20
40
60
80
100
120
140
160
180
200
N
o
 o
f 
o
b
s
 
Grade 1- Not satisfied, Grade 2- Not quite satisfied, Grade 3- Moderately satisfied, Grade 
4- Very satisfied. 
91% of respondents were very satisfied with the level of support they received from their 
families. 
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Figure 14: Histogram of patients receiving support from outside. 
Histogram of 206 SUPPORT OUTSIEDE
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Y-Yes, N- No. 
57% responded yes to receiving support from outside the home or their families. 
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Figure 15: Histogram of where patients receive support from outside 
Histogram of 207 WHERE
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GF- government facility, RBO- Religious based organisation, NGO- Nongovernmental 
organisation, CBO-Community based organisation, Others – Friends, neighbours etc. 
33% received support from government facilities, 17% and 9%received support from 
religious based organisations and community based organisations respectively, 11% from 
non governmental organisations and 29% received support from others. 95% of 
respondents who receive support from outside the home were very satisfied with the kind 
of support they received which to a large extent (54%) was psychological support 
followed by physical care in 29% of respondents.  
65% of respondents said family and friends always helped them to remember to take their 
medication. 61% of respondents had HIV positive spouses/partners, 25% had HIV 
negative partners and 14% had no partners. 
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44% of respondents answered yes to having other family members who were also HIV 
positive. Of the number of HIV positive relatives, 73% were also on antiretroviral 
medication. 
12% of respondents gave a history of alcohol use and of these 60% gave a history of 
using more than 3-4 drinks per episode of drinking. Only 1patient(<1%) of the whole 
sample responded yes to the use of recreational drugs (marijuana). 
 
Figure 16: Histogram of patients on ARV in the past. 
Histogram of 401 ARV PAST
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When questioned about antiretroviral therapy 85% of patients were currently on 
treatment, 5% had stopped therapy for various reasons and 10% had never been on 
therapy or were commenced on treatment less than 2 weeks before answering the 
questionnaire. The 5% here had a history of previous antiretroviral therapy that was 
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stopped for various reasons. 20% of this group of patients showed a rise in their CD4 
count, 30% of patients remained within the same level (20% with CD4 less than 50 and 
10% over 200). 40% of patients had only one CD4 recording and so it was not possible to 
comment on the CD4 count although all CD4 counts in this group were less than 250. 
10% of these patients had an obvious drop in CD4 count. 
 
Figure 17: Histogram of REASON for defaulting therapy. 
Histogram of 402 REASON
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 Patients were asked to give reasons for stopping their antiretroviral therapy. The 
following reasons were listed and they could make choices from the list of reasons. A-
Financial difficulties, B- ARVs had too many side effects, C- felt sicker with medication, 
D- Was worried about side effects of drugs, E- Too busy doing other things, F- 
Travelling so could not keep the routine, G- Did not want anyone to know, H- Felt better 
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so did not feel the need to continue medication, I- Found it very difficult to take so many 
pills, J- Health worker told me to stop, K- Other reasons. The histogram as above reflects 
the reasons patients gave for defaulting therapy. 31% gave a history of stopping on 
instruction of health workers, 21% said they were travelling and could not keep the 
routine, 17% were too busy doing other things, 7% stopped because they felt better, 7% 
stopped because they were worried of the side effects, 7% stopped due to financial 
difficulties, 3% felt sicker with medication and 7% stopped for other reasons not included 
in the list. As is seen in the histogram no patients selected the options B,G or I and so 
these letters are not represented in the histogram. 
 
Figure 18: Histogram of Total number of opportunistic infections. 
 
Histogram of Total number of Ois
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58% of patients had 1 opportunistic infection, 18% had  2 opportunistic infections in the 
past and 3% had 3 opportunistic infections, 21% of patients had no opportunistic 
infections.  
 
 
 
 
 
 
 
 
Figure 19: Histogram of CD4 count distribution before starting antiretroviral therapy. 
Histogram of 505  CD4 COUNT START
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The South African guidelines for starting antiretroviral therapy is used in this clinic, 
patients who have stage 4 disease sometimes had CD4 count of above 200 and were 
commenced on therapy. However as reflected by this histogram less than 20% of the 
study population had CD4 count greater than 200 at the start of antiretroviral therapy. 
Figure 20: Histogram of distribution - recent CD4 count. 
Histogram of 506  CD4 COUNT PRESENT
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This histogram reflects that about 80% of patients had CD4 count improving to above 
200 after commencing antiretroviral therapy compared to the previous histofram where 
less than 20% of patients had CD4 above 200. 
Figure 21:  CD4 before starting therapy 
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Summary: 505  CD4 COUNT START
K-S d=.15888, p<.01 ; Lilliefors p<.01
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Summary Statistics:505  CD4 COUNT START
Valid N=185
Mean=140.167568
Median=130.000000
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Std.Dev.=126.754637
 
Figure 22:  CD4 COUNT RECENT 
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Wilcoxon Matched Pairs Test (DATA 20090814.sta) 
Wilcoxon Matched Pairs Test (DATA 20090814.sta)
Marked tests are significant at p <.05000
Pair of Variables
Valid
N
T Z p-value
505  CD4 COUNT  START & 506  CD4 COUNT PRESENT124 298.00008.9198810.000000
 
 
Figure 23: Box & Whisker Plot 
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Figure 24: Histogram of VL START 
Histogram of VL START
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Figure 25: Histogram of VL NOW 
Histogram of VL NOW
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VL – viral load. 
 
As with the CD4 count the histograms of the viral load at the start of antiretroviral 
therapy and more recently reflect a drop in viral load. At the start of therapy 79% of 
patients had viral load in the 0 to 500000 copies per ml range, the recent viral load after 
patients had been on therapy for a while showed that 76% of patients had undetectable 
viral loads which is shown here as 0. 
Figure 26:  VL START 
Summary: VL START
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VL – viral load 
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Figure 27:  VL NOW 
Summary: VL NOW
K-S d=.41099, p<.01 ; Lilliefors p<.01
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Summary Statistics:VL NOW
Valid N=111
Mean=3047.657658
Median=  0.000000
Mode=  1.000000
Frequency of Mode= 84.000000
Minimum=  0.000000
Maximum=100000.000000
Lower Quartile=  0.000000
Upper Quartile=  0.000000
Std.Dev.=13438.604768
 
VL – viral load 
Wilcoxon Matched Pairs Test (DATA 20090814.sta) 
Wilcoxon Matched Pairs Test (DATA 20090814.sta)
Marked tests are significant at p <.05000
Pair of Variables
Valid
N
T Z p-value
VL START & VL NOW 68 173.0000 6.1103530.000000
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Figure 28: Box & Whisker Plot 
Box & Whisker Plot
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Statistic calculations reflecting a significant rise in CD4 count and drop in viral load 
variables when comparing levels at start of therapy and recent levels in patients on 
antiretroviral therapy. 
 
Discussion of Results. 
This study has attempted to define the factors that influence adherence at the clinic under  
study. The factors defined in the different arms of the study reveal that socioeconomic 
factors play a large role in patient adherence. 
In the course of the focus group discussions, patient factors revealed included 
psychosocial factors that influence patients’ emotional stability and directly influence 
their adherence to antiretroviral therapy. A factor that featured quite prominently in the 
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course of the discussions is the need for family support. A lot of patients defaulted 
therapy on account of not having adequate family or partner support, the need to be 
accepted without having to hide their status from family and friends. A number revealed 
how the negative stigma in the community influenced how they were shut out by family 
and close friends. The guideline
10 
of patient adherence highlights the role of emotional 
and practical life supports in patient adherence to antiretroviral. The problems of neglect 
by family were associated with depression and alcohol abuse in some patients. The use 
and abuse of alcohol by patients in resource poor settings is also associated with poor or 
non adherence among patients on antiretroviral therapy.   
They also highlighted the need to have better health worker and patient relationships. 
This is widely recognized in many studies as a good way of encouraging adequate 
adherence among patients
8
. The clinician needs to understand the context of the patients 
and avoid a judgemental approach in discussing adherence to medication among patients. 
There is a need to foster strong relationships with patients, relationships based on trust. 
Patients in this study highlighted their dissatisfaction with the judgemental attitude often 
taken by health workers in the course of discussing issues relating to adherence. Clearly 
revealed in the discussions is the fact that patients understand fully the implication of 
poor adherence. They also know when they are not adhering to therapy as most were 
quite to the point in agreeing to being poorly adherent to their medication. They pointed 
out in some instances their use and abuse of alcohol and how it influenced their 
adherence to medication. The use of alcohol in the resource poor setting is an accepted 
norm and patients admitted episodes of abuse that led to defaulting therapy as they did 
not want to use alcohol and the antiretroviral therapy together. 
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The semistructured interviews revealed similar causes of poor adherence, patients 
highlighted the lack of family support, the difficulties experienced in not being able to 
take their medication in the presence of people outside their home environment for fear of 
being identified as HIV positive, they expressed the fears of family neglect, the 
difficulties of dealing with other comorbidities that directly influenced their adherence to 
antiretroviral medication.  25% of the patients interviewed revealed they were poorly 
adherent to medication. They sited reasons that varied from the lack of family support 
structures to fear of the side effects and the difficulties of their comorbidities. A fear of 
disclosure in the community ranked high among the group of patients in the 
semistructured interviews and in the course of both focus group discussions. Some 
mentioned the challenges of financial constraints, not being able to afford food or 
transport costs to the clinic appointments. This is similar to findings of other qualitative 
studies that highlight patient related factors as the main factor influencing poor or non 
adherence. 
The quantitative study used a questionnaire that asked about sociodemographic features 
and then went on to ask about family support systems, community support and issues 
concerning drug therapy and disease control. The majority of patients were secondary 
school level educated (see fig.3) and this could negatively impact the understanding of 
the pharmacodynamics of medicaton and their side effects. A large number had access to 
electricity (see fig. 6) and pipe borne water(89%) (see fig.7) in their homes revealing that 
they were not all indigent. This said however, patients in the majority were unemployed 
(86%) (see fig. 9), showing that there is a high rate of financial constraints. 99% had 
disclosed to family (see fig. 11) and 57%  to community members. When asked about 
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satisfaction with family support only 65% were very satisfied with the support they 
receive from family members (see fig. 13). Very few compared to the whole number 
were poorly adherent to medication and the major factor influencing poor or non 
adherence was due to work related commitments or travelling and an inability to keep up 
with drug schedule (see fig. 17). These are similar to the findings of a study carried out in 
Soweto (Nachega et al)
13
 among patients on antiretroviral therapy where patients listed 
among the reasons for poor adherence as being away from home, difficulty with dosing 
schedules and running out of pills.  
The assessment of CD4 levels at the start of treatment (mean CD4 - 185) and currently 
(mean CD4 - 408) among these patients revealed an improvement in CD4 cell levels (see 
fig. 24). There was also a general decline in viral load levels among these patients (see 
fig. 28). From studies done so far clinical failure secondary to adherence is rare but 
patients especially in the 80 -90% adherence bracket are very likely to develop resistant 
strains of the virus which is cause for worry as this limits the therapeutic options for 
patients. 
Limitations 
The focus group discussions were carried out in groups of 20 people per episode the 
patients may have had reservations in disclosing fully all the factors that influence their 
adherence to therapy. 
The findings of this study are context specific and may not be transferable to other 
studies elsewhere. 
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CONCLUSION.    
Adherence is dynamic and can not be judged by one measurement, it should be measured 
as part of an ongoing clinical assessment of patients during clinic visits. The factors 
highlighted in this study show that the need for emotional support plays a large role in 
patient adherence to therapy, also important is the need to address the fear of disclosure 
among patients which deters them from taking medication outside the home. 
Socioeconomic factors like lack of food, inability to afford transport to appointments, 
alcohol abuse which seems to be an accepted norm in the community, the need for strong 
patient – caregiver relationships are also highlighted as in other studies similar to this 
one.  These factors should serve as a guide in developing interventions aimed at 
improving the adherence to therapy among patients on antiretroviral therapy. 
Unfortunately the stigma of HIV is not one that can be easily removed. However, 
developing strategies that will aid patient and community awareness through continued 
education of the community will go a great length in taking the first few steps required to 
move away from the present predicament. 
 
Recommendations. 
- The problem of adherence should be assessed in every patient attending the clinic 
at regular intervals as every patient is a potential poorly adherent patient.  
- All patients should get regular psychologist review to assess the social stressors 
they have and what can be done to allay their difficulties 
- The community served by Dora Nginza hospital is a resource poor community. It 
needs community development initiatives that will aid the people to draw strength 
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from one another as a collective. The ideas for this intervention should be 
developed with direct input from those most affected by the problem i.e. patients 
and community members. 
- The social welfare system has developed grants to help patients, it is important to 
get their input in building a project that addresses HIV positive individuals 
directly. The aim is not to give money to these patients but to get them involved 
in self improvement initiatives. 
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QUESTIONNAIRE -  ADDENDUM 1 
Instructions 
 To be administered once per patient and each patient is assigned a code. 
 To be administered by the Adherence Counselor nurse 
 The adherence nurse counselor should have obtained informed consent for the 
study prior to administering this questionnaire. Signed consent form to be stored 
in the Master file. 
 
 
SUBJECT CODE                                               ------------------
--- 
 
DATE:                                                      [____/_____/____]  DD/MM/YY  
 
TREATMENT SITE:                               _______________ 
 
AGE:                                                                    
_______________ 
   
SEX:                                _______________ 
  
Adherence Nurse Counselor Code:                  _______________ 
 
Research Interviewer code:                               
_______________ 
 
Informed Consent obtained:            Yes                          1      
                                                             No                           2   
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Date of Informed consent:                                 [____/_____/____]  DD/MM/YY 
 
 
The signed Informed Consent Form for the patient should be collected and 
placed in the Master file by the Research coordinator. 
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Start Time [___|___]:[___|___] 
Section I - Demographic information 
Questions and Filte      Coding categories  
 
Responses 
101 What is your highest educational 
level? 
 
 
(Completed years) 
Never attended school 
Preschool 
Primary school (Grade…) 
Secondary school (Grade…) 
Vocational / Technical school 
Diploma 
University level 
Adult literacy 
 
01 
02 
03 
04 
05 
06 
07 
08 
102 What is your current marital 
status? 
 
Married  
Cohabiting  
Never married 
Divorced or separated 
Widowed 
 
01 
02 
03 
04 
05 
103 Who do you currently live with? 
  
 
(Multiple responses possible. 
After respondent answers, 
probe by asking for any others) 
 
Do NOT read out answers. 
 
 
M= Mentioned  
NM= Not Mentioned 
 
a) By your self 
b) Partner/spouse 
c) Parents 
d) Siblings 
e) Children 
f) Relatives 
g) Friends / Roommates 
h) Other (specify)___________________ 
 
 
 
M  
NM 
1       2 
1       2 
1       2 
1       2 
1       2 
1       2 
1       2 
1       2 
 
104 What type of accommodation do 
you live in?  
 
Own independent house /flat 
Rented independent house / flat 
Informal housing 
Hostel for students 
Rented room 
Homeless  
Others (specify)_____________ 
 
01 
02 
03 
04 
05 
06 
88 
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105  Are the following facilities 
available at your home? 
 
 
Read out 
 
Y= Yes 
N= No 
 
a) Electricity  
b) Refrigerator           
c) Radio    
d) Television            
e) Bicycle              
f) Motorcycle   
g) Car   
     
 
 
Y     
N 
1       2 
1       2 
1       2 
1       2 
1       2 
1       2 
1       2 
 
106 What source of water do you use 
at home? 
 
 
        Piped water to your house/plot 
  Piped water from community tap 
  Well / bore water 
  Purchased water 
Others (specify)____________________ 
01 
02 
03 
04 
88 
107 What kind of toilet do you use at 
home?  
 
Own flush toilet 
Shared flush toilet 
                         Own traditional pit latrine 
Shared traditional pit latrine 
Own ventilated improved toilet  (VIP) 
Shared VIP 
No latrine facilities 
  Others (specify)______________________ 
 
01 
02 
03 
04 
05 
06 
07 
88 
108 Are you employed?  
 
Yes  
No 
01 
02 
 
If no 
skip to 
112 
 72 
 
109 Do you work on full time or 
part time basis? 
 
 
Full time work 
Part time work 
 
01 
02 
110 What is your occupation? 
 
Professional (e.g. teacher, doctor, 
engineer etc) 
Skilled      (e.g. clerk, welder etc) 
Unskilled  (e.g. cleaner, gardener etc) 
Others (specify)__________________ 
 
 
01 
 
02 
03 
88 
111 What is your home district? 
 
       
       
      Specify) ___________________ 
 
 
 
88 
112 How long have you lived in P.E.? 
 
 
Instruction: enter only 1 
category: Weeks, Months, or 
Years. 
 
Weeks 
Months 
Years 
 
Does not live in P.E. 
[___|___] 
[___|___] 
[___|___] 
 
99 
    
 
Section 2:  Social support 
 
201 Have you disclosed your HIV 
status to anyone? 
 
Yes 
No 
 
01 
02 
 
 
If no 
skip to 
204 
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202 If yes, whom have you disclosed 
your status to?  
Multiple responses possible. 
After respondent answers, 
probe by asking for any others) 
 
Do NOT read out answers. 
 
 
M= Mentioned  
NM= Not Mentioned 
 
a) Partner / spouse 
b) Parent 
c) Sibling 
d) Other Relatives 
e) Friends 
f) Neighbours / community members 
g) Friends / Roommates 
h) Other (specify)___________________ 
 
 
 
M  
NM 
1       2 
1       2 
1       2 
1       2 
1       2 
1       2 
1       2 
1       2 
 
203 Why did you disclose your HIV status to these persons? 
 
 
 
 
 
 
 
 
 
Open 
ended 
answer 
 
 
 
204 What kind of support do you get 
from your family and friends?  
 
 
(Multiple responses possible. 
After respondent answers, 
probe by asking for any others) 
 
Do NOT read out answers. 
M= Mentioned  
NM= Not Mentioned 
 
a) Encouragement / psychological support 
b) Financial support 
c) Physical care and support 
d) No support 
e) Other (specify)__________________ 
 
 
 
 
 
M  
NM 
1       2 
1       2 
1       2 
1       2 
1       2 
 
If none 
skip to 
206 
205 In general, how satisfied are you 
with the overall support (help) 
you get from your family? 
 
Not satisfied 
Not quite satisfied 
Moderately satisfied 
Very satisfied 
01 
02 
03 
04 
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206 Do you receive support from 
outside your home or family 
members?  
 
 
Yes 
No 
 
01 
02 
 
If no 
skip to 
210 
207 From where do you get support? 
Multiple responses possible. 
After respondent answers, 
probe by asking for any others) 
 
Do NOT read out answers. 
 
M= Mentioned  
NM= Not Mentioned 
 
a) NGO 
b) Community based organization 
c) Religious based organization 
d) Government facility 
e) Other (specify)___________________ 
 
 
 
M  
NM 
1       2 
1       2 
1       2 
1       2 
1       2 
 
208 What kind of support do you get 
from these organizations? 
 
 
(Multiple responses possible. 
After respondent answers, 
probe by asking for any others) 
 
Do NOT read out answers. 
M= Mentioned  
NM= Not Mentioned 
 
a) Psychological support 
b) Financial support 
c) Physical care and support 
d) Income generating activities 
e) Nutritional support 
f) Legal support 
g) Other (specify)___________________ 
 
 
 
M  
NM 
1       2 
1       2 
1       2 
1       2 
1       2 
1       2 
1       2 
 
209 In general, how satisfied are you 
with the overall support you get 
from outside your home? 
 
Not satisfied 
Not quite satisfied 
Moderately satisfied 
Very satisfied 
01 
02 
03 
04 
210 To what extent do your friends or 
family members help you to 
remember to take your 
medications? 
Never 
Occasionally 
Sometimes  
Always 
01 
02 
03 
04 
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211  Do you know your spouse’s / 
partner’s HIV status? If yes, what 
is your partner’s status? 
 
 
Yes positive 
                                                   Yes negative 
Don’t know 
Not applicable 
01 
02 
03 
04 
212 Is there anyone else in your family 
who is HIV infected? 
 
Yes 
                                                                  No 
01 
02 
 
If No, 
skip to 
301 
213 How many persons are HIV 
infected? 
 
Number of persons infected 
Don’t know 
 
[___|___] 
[___] 
214 Who are they? 
 
 
(Multiple responses possible. 
After respondent answers, 
probe by asking for any others) 
 
Do NOT read out answers. 
 
M= Mentioned  
NM= Not Mentioned 
 
a) Spouse 
b) Children 
c) Sibling 
d) Other (specify)___________________ 
 
 
 
M  
NM 
1       2 
1       2 
1       2 
1       2 
 
215 Is there anyone else in your family 
taking ARV medications? 
 
Yes 
                                                                   No 
01 
02 
 
 
If No, 
skip to 
301 
   
 
 
216 Who are they? 
 
(Multiple responses possible. 
After respondent answers, 
probe by asking for any others) 
 
Do NOT read out answers. 
 
M= Mentioned  
NM= Not Mentioned 
 
a) Spouse 
b) Children 
c) Sibling 
d) Other (specify)___________________ 
 
 
 
M  
NM 
1       2 
1       2 
1       2 
1       2 
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Section 3 Alcohol and drug use 
 
 
301 How often have you had an 
alcoholic drink in the last 30 
days? 
 
Never 
Once a month 
                                     2-3 times a month 
                                Once or twice a week 
                                       3-4 times a week 
                                      Nearly every day 
                                                         Daily 
01 
02 
03 
04 
05 
06 
07 
 
If never 
skip to 
304 
 
302 On the days when you drank any 
alcoholic drinks in the past 30 
days, how many drinks did you 
usually have altogether on an 
average day? 
Drink =  
o One 300ml glass or 
bottle of beer   
Or  
o 45 ml (1.5 oz) of 
liquor  
 
1-2 / day    
3-4 / day 
5-6 /day 
7-8/ day 
9-11/day 
12 or more/ day 
 
01 
02 
03 
04 
05 
06 
303 During the past 30 days, how 
often have you had 5 or more 
drinks of alcohol within a couple 
of hours? 
 
 Never 
Once a month 
2-3 times a month 
Once or twice a week 
3-4 times a week 
Nearly every day 
                                                         Daily 
 
01 
02 
03 
04 
05 
06 
07 
DRUG USE 
    
304 
Have you ever used recreational 
drugs? 
Have you used these in the last 
6 months? 
  
1 Yes 
2 No  
 
 
1 Yes 
2 No  
 
 
      01 Once a month 
      02 2-3 times a month 
      03 Once or twice a week 
      04 3-4 times a week 
      05 Nearly every day 
      06 Daily 
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Section 4 Past use of ARVs  
 
401 Have you ever taken ARV 
medications in the past?  
 
 
Yes, taking presently 
Yes, not taking presently 
No 
Don’t know 
01 
02 
03 
99 
If no 
skip to 
501 
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402 If yes, but not taking them 
presently, please give the names 
and doses of the medications you 
were taking in the past and for 
how long (date started / date 
stopped)? 
In case the respondent does not 
recall the names of medications 
please fill in DR 
 
(Multiple responses possible. 
After respondent answers, 
probe by asking for any others) 
 
Do NOT read out answers. 
 
 
Name & dose 
 
Eg     AZT 300 mg  
Date 
started  
 
MM/YR  
 
Date 
stopped 
 
MM/YR 
 
Reasons 
for 
stopping 
Tmt with 
ARVs 
 
(See codes 
below) 
 
 
 
 
[___/___] 
 
 
[___/___] 
 
 
 
 
 
 
 
[___/___] 
 
 
[___/___] 
 
 
 
 
 
 
 
[___/___] 
 
 
[___/___] 
 
 
 
 
 
 
 
[___/___] 
 
 
[___/___] 
 
 
 
 
 
 
 
[___/___] 
 
 
[___/___] 
 
 
 
 
Please select reasons for stopping from the following: 
Reasons for stopping treatment 
01 Financial difficulties 
02 ARVs had too many side effects 
03 Felt sicker with medications 
04 Was worried about side effects/toxicities 
05 Too busy doing other things 
06 Traveling so could not keep the routine 
07 Did not want anyone to know 
08 Felt better so did not feel the need to continue 
medication  
09Found it very difficult to take so many pills  
10 Health worker told me to stop 
88 Others (specify)_____________ 
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403 If you stopped treatment due to 
financial difficulties, please tell 
me; 
 (a) How much you were paying 
for these medications every 
month? 
(b) How many months in total did 
you take them for?  
 
 
 
  
A) Average Cost per month    [___|___|___|___|___] R  c   
 
B) Duration medications taken for           [___|___] months 
 
404 If yes and continuing to take 
treatment presently, please tell 
me the doses and names and 
when started  
 
 
 
 
Name & dose 
 
Eg AZT 300mg one tablet two 
times/day 
Date started 
 
Month/year 
 
 
 
 
[___/___] 
 
 
 
 
 
[___/___] 
 
 
 
 
 
[___/___] 
 
 
 
 
 
[___/___] 
 
 
 
 
[___/___] 
 
 
 
Section 5 Disease characteristics (to be collected from Study subjects and Medical 
records.  
 
501  WHO Clinical stage of HIV 
disease  
 
Stage                                 Date  
 
Stage I                [___/___/___] 
Stage II              [___/___/___] 
Stage III             [___/___/___] 
Stage IV             [___/___/___] 
                 [DD/MM/YY] 
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502 List OIs (Opportunistic 
Infections) and number of 
episodes  
 
Data to be collected from 
medical records  
 
 
 
Time Names of OIs 
(Opportunistic 
Infections) 
Date of 
admission/ got 
medial attn 
MM /YR  
 
1   
2   
3   
4   
5   
 
Total number of OIs  [___|___] 
 
503  Please tell me how many times 
have you been hospitalized—and 
the reasons why—for HIV related 
illnesses over in the past 12 
months. 
 
Based on patient history or 
discharge slips) 
Time Reason for 
hospitalization 
Date of 
admission 
MM /YR  
 
1   
2   
3   
4   
5   
 
Total number of hospitalizations  [___|___] 
 
504 Date of first HIV test 
(Ask patient)  
 Date of test [___/___/___] 
                 [DD/MM/YY] 
 
505 CD4 counts at start of 
treatment/Date of test 
 
 
(Collect from patient –first visit 
records) 
 
CD4 count presently/ Date of test 
(Collect from patient records) 
 
CD4 count     [___|___|___][___|___] 
 
Date of Test       [___/___/___] 
                 [DD/MM/YY] 
 
 
CD4 count [____________] 
Date of Test       [___/___/__] 
[DD/MM/YY]      
 
506 VL (Viral load) at start of 
treatment / Date of test 
 
  
 
 
VL(Viral load) currently / Date of 
test 
 
           
Initial VL count     [________________] 
 
Date of Test       [___/___/___] 
                 [DD/MM/YY] 
 
Current VL count     [________________] 
Date of Test [___/___/___] 
[DD/MM/YY]   
507 Height  / date 
 
 
 
 
Height         [___]Feet  [___|___] Inches 
Date                                  [___/___/___] 
                 [DD/MM/YY] 
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508 Weight / date 
  
 
 
 
Weight        [___|___|___].[___|___] Kg 
Date                                 [___/___/___] 
                 [DD/MM/YY] 
 
End Time [___|___]:[___|___]   
 
THANK YOU FOR YOUR TIME!! 
 
ADDENDUM 2. 
 
Questions for Semi structured Interviews 
 
1. Semi structured interview questions. Sourced from AETC National Resource centre 
clinical manual of adherence, questions to ask patients on antiretroviral therapy.  
 
1. Do you manage your own medication? If not, who manages them for you? 
2. What HIV medication do you take and what is their dosage? When do you take these? 
3. How do you remember to take your medication? 
4. How many doses of your medication have you missed in the last 3 days, in the last 1 
week, in the last 2 weeks, in the last month? 
5. On a scale of 1 to 10, where would you say you are with adherence to your medication 
1 is that you don’t take it all and 10 is that you take every dose at the same time every 
day. 
6. If you are not a 10 what is the reason(s) you are not a 10? 
7. When are you most likely to miss doses? 
8. Do you have side effects to your antiretroviral therapy? If so what are they? 
9. Are you comfortable taking medication in front of others? 
10. What is the most difficult problem you have taking your medication? 
11. What is your current CD4 count, when was it tested? 
12. What is your most recent viral load? 
13. What was your previous CD4 count? 
14. Do you have family/social support in your fight against this disease? 
Interviewer will then evaluate patient’s pharmacy refill records which are available in 
folder and record details of records for preceding 3 months.   
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ADDENDUM 3 
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ADDENDUM 4 
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ADDENDUM 5 – Informed Consent. 
 
Informed Consent. 
 
Title of Research Project: What are the main factors influencing adherence to 
antiretroviral therapy at the Dora Nginza Hospital Adult Wellness Clinic? 
 
Reference Number: 
 
Principal Investigator: Dr Febisola I Ajudua. 
 
Address: Eastern Cape Department of Health  
               Dora Nginza Hospital. 
 
Contact Number: O832694029 
 
You are being invited to take part in a research project. Please take time to read the 
information presented here, which will explain the details of this project. Please ask the 
study staff or doctor any questions about any part of this project that you do not fully 
understand. It is very important that you clearly understand what this research entails and 
how you could be involved. Also, your participation is entirely voluntary and you are free 
to decline to participate. If you say no, this will not affect you negatively in any way 
whatsoever. You are also free to withdraw from the study at any point, even if you do 
agree to take part.  
This study has been approved by the Committee for Human Research at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
International Declaration of Helsinki, South African Guidelines for Good Clinical 
Practice and the Medical Research Council (MRC) Ethical Guidelines For Research. 
 
This study is to be conducted at the Dora Nginza Hospital Wellness clinic and a total 
number of 250 patients are to be recruited for the various aspects of the study. The study 
is aiming to describe the prevalent factors influencing adherence to antiretroviral therapy 
among patients at this clinic. Three methods will be used to gather information in depth 
interviews which will be conducted by the medical staff of the clinic with participating 
patients, focused group discussions which will be conducted among patients with the help 
of  a facilitator who is a member of staff at the clinic and the principal investigator and a 
questionnaire of not more than 25 questions that will be filled by patient answering 
questions relevant to the topic of this study. The sampling of patients for this study has 
been conducted randomly and so not all patients attending this clinic will participate in 
the study only patients selected by the random sampling process. 
You have been invited to join in the study as you have been randomly selected among the 
patients to be included in this study.  
Your responsibility will include participating in the study as you have been counseled by 
the medical staff. This will involve you answering questions in an indepth interview/ 
participating in a focused group discussion/ answering he questionnaire with the help of 
the member of staff explaining this procedure to you. 
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It must be explained clearly to you at this point that there will be no personal benefits to 
you aside of the general benefits to be gained from the knowledge of the results of this 
study that will enable us to make recommendations to assist patients in improving their 
adherence to the antiretroviral therapy. There are no personal risks involved in your 
participation in this study. The results and the findings of the study are strictly 
confidential and access to the records of the study is only accessible to the principal 
investigator and no one else. You will not be required to personally identify yourself at 
any point in the whole proceedings. There is no monetary remuneration for your 
involvement in this study and there are no costs to you as a participant in the study. 
You can contact the Wellness clinic staff if you have any further queries about this study 
at this number 041 406???? 
You will receive a copy of this consent form for your own records. 
 
By signing below, I -------------------------------------- agree to take part in a research study 
entitled ‘What are the prevalent factors influencing adherence to antiretroviral therapy at 
the Dora Nginza Hospital Wellness Clinic?’ 
 
I declare that  
 I have read OR had read to me this information and consent form and it is written 
in a language with which I am fluent and comfortable 
 I have had a chance to ask questions and all my questions have been adequately 
answered 
 I understand that taking part in this study is voluntary and I have not been 
pressurized to take part 
 I may choose to leave the study at any time and will not be penalized or 
prejudiced in any way 
 I may be asked to leave the study before it has finished, if the study Doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan as 
agreed to  
 
Signed at ------------------------------------ on ------------------------------2009. 
 
 
 
----------------------------------------------                             ---------------------------------------- 
Signature or thumbprint of participant                              Signature of witness  
 
Declaration by investigator. 
I Dr F.I. Ajudua declare that:- 
 I explained the information in this document to ---------------------------- 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above 
 I did/did not use a translator. 
 
Signed at ------------------------------- on -----------------------------2009. 
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--------------------------------                                                -------------------------------------- 
Signature of investigator                                                    Signature of witness. 
 
ADDENDUM 6 
  
The Medical Superintendent, 
Dora Nginza Hospital, 
Port Elizabeth Hospital Complex. 
Port Elizabeth. 
 
Dear Sir, 
 
LETTER FOR PERMISSION TO CONDUCT RESEARCH 
 
I hereby apply for permission to conduct research in the Adult Wellness clinic of the 
Dora Nginza hospital 
 
I am currently a third year post graduate student of the Division of Family Medicine and 
Primary Care, Faculty of Health Sciences, Stellenbosch University and the topic of my 
Thesis is: ‘Adherence to antiretroviral therapy at the Dora Nginza hospital adult wellness 
clinic, Port Elizabeth South Africa “ The study is set in the wellness clinic of Dora 
Nginza Hospital.  
 
I would be much obliged if you would grant me permission to go ahead with this project.  
 
In addition please find copies of ethics approval from the university of Stellenbosch 
Ethics committee as well as a copy of the research protocol attached for your perusal.. 
 
Kind regards and best wishes. 
 
 
 
 
 
----------------------------------------- 
Dr Febi Ajudua. 
 
